Clinical Trial Update: DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins

View source ↗

Summary

A Department of Defense-funded clinical trial at MD Anderson Cancer Center aims to identify metabolic markers and develop a statistical method to rapidly diagno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor
• Neurofibromas

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neurofibromas, MPNST | Status: RECRUITING